RxDoctor Payments Data

Ryan Wineinger

Optometrist · Shawnee, KSNPI 1053494401

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,145 of the $13,357 with a category attached, or 76.0%. Carl Zeiss Meditec, Inc. accounts for 76.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $6,482 and has fallen 73.0% since, to $1,748 in 2025. Among optometrist clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,357in general payments, 2019–2025

Across 63 payments — averaging $212.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec, Inc.$10K
  • Alcon$2K
  • Johnson & Johnson Vision Care, Inc.$897
  • Carl Zeiss Meditec USA, Inc.$158
  • Carl Zeiss Meditec AG$19

What the payments were for

  • Consulting fees$10,14576%
  • Travel & lodging$7436%
  • Food & beverage$2,45018%
  • Gifts$190%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,357 in reported general payments places this provider in the 95th percentile of 567 optometrist providers in Kansas.

See all optometrist providers in Kansas

Medicare billing

Part B allowed, 2024
$20,476
Medicare patients
134
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost73$1,044
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha44$524

Paid to pharmacies, not to this prescriber.

Other optometrist in Shawnee

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →